S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

HRMY Harmony Biosciences Holdings Inc

34.83

0.12 (0.35%)

Nov 26 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

03/08/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

12/07/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Jeffrey G Dierks

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Harmony Biosciences (NASDAQ:HRMY)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Harmony Biosciences Charts.

Harmony Biosciences (NASDAQ:HRMY)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Harmony Biosciences Charts.

Harmony Biosciences Holdings Inc News

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
Thursday 21 November 2024 (6 days ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 31 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 424B7 - Prospectus [Rule 424(b)(7)]
Thursday 31 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
Wednesday 30 October 2024 (4 weeks ago) • PR Newswire (US)

Form 424B7 - Prospectus [Rule 424(b)(7)]
Tuesday 29 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders
Tuesday 29 October 2024 (4 weeks ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Tuesday 29 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 29 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 29 October 2024 (4 weeks ago) • Edgar (US Regulatory)

HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS
Tuesday 29 October 2024 (4 weeks ago) • PR Newswire (US)

More Harmony Biosciences Holdings Inc News Articles

Cassava Sciences

Enanta Pharmaceuticals

Anavex Life Sciences

Moon Equity (PK)

Digital Brand Media and ... (PK)

AMC Entertainment

Brookmount Explorations (PK)

Global Developments (PK)

ERHC Energy (CE)

Kraig Biocraft Laborator... (QB)

Sincerity Applied Materi... (PK)

Lightwave Logic

Good Vibrations Shoes (PK)

NioCorp Developments

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions